Integra LifeSciences is one of the world leaders in regenerative medicine. The company develops, manufactures and markets cost-effective surgical implants and medical instruments. The company now manufactures and sells products in the following two global reportable business segments: Codman Specialty Surgical (CSS) and Orthopedics and Tissue Technologies (OTT). The CSS business offers global, market-leading technologies, brands and instrumentation. The global commercial network includes clinical specialists, a large direct global sales force and strategic partnerships and distributors that serve hospitals, integrated health networks, group purchasing organizations, clinicians, surgery centers and health care providers in North America, South America, Europe, Asia Pacific, Middle East and Africa. The Tissue Technologies segment includes wound reconstruction and repair products, bone grafts and nerve and tendon repair products.
| Revenue (Most Recent Fiscal Year) | $1.61B |
| Net Income (Most Recent Fiscal Year) | $-6.94M |
| PE Ratio (Current Year Earnings Estimate) | 5.66 |
| PE Ratio (Trailing 12 Months) | 5.24 |
| PEG Ratio (Long Term Growth Estimate) | 0.71 |
| Price to Sales Ratio (Trailing 12 Months) | 0.61 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 0.64 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 2.85 |
| Pre-Tax Margin (Trailing 12 Months) | -2.65% |
| Net Margin (Trailing 12 Months) | -1.78% |
| Return on Equity (Trailing 12 Months) | 12.12% |
| Return on Assets (Trailing 12 Months) | 4.58% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.21 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.72 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.81 |
| Inventory Turnover (Trailing 12 Months) | 1.74 |
| Book Value per Share (Most Recent Fiscal Quarter) | $19.61 |
| Earnings per Share (Most Recent Fiscal Quarter) | $0.41 |
| Earnings per Share (Most Recent Fiscal Year) | $2.56 |
| Diluted Earnings per Share (Trailing 12 Months) | $-0.38 |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 77.71M |
| Free Float | 74.96M |
| Market Capitalization | $985.39M |
| Average Volume (Last 20 Days) | 1.57M |
| Beta (Past 60 Months) | 1.27 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 3.54% |
| Percentage Held By Institutions (Latest 13F Reports) | 84.78% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |